Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	MIR	RYR2 RYR3 SDF2L1	5.28e-05	10	145	3	PF02815
Domain	MIR_motif	RYR2 RYR3 SDF2L1	5.28e-05	10	145	3	IPR016093
Domain	MIR	RYR2 RYR3 SDF2L1	5.28e-05	10	145	3	PS50919
Domain	MIR	RYR2 RYR3 SDF2L1	5.28e-05	10	145	3	SM00472
Domain	Ryanodine_rcpt	RYR2 RYR3	1.79e-04	3	145	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR2 RYR3	1.79e-04	3	145	2	IPR009460
Domain	RyR	RYR2 RYR3	1.79e-04	3	145	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	1.79e-04	3	145	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	1.79e-04	3	145	2	IPR013333
Domain	G8_domain	CEMIP PKHD1	3.56e-04	4	145	2	IPR019316
Domain	G8	CEMIP PKHD1	3.56e-04	4	145	2	PS51484
Domain	G8	CEMIP PKHD1	3.56e-04	4	145	2	SM01225
Domain	G8	CEMIP PKHD1	3.56e-04	4	145	2	PF10162
Domain	TSP_3	THBS1 THBS3	5.89e-04	5	145	2	PF02412
Domain	TSP3	THBS1 THBS3	5.89e-04	5	145	2	PS51234
Domain	TSP_CTER	THBS1 THBS3	5.89e-04	5	145	2	PS51236
Domain	Thrombospondin_3_rpt	THBS1 THBS3	5.89e-04	5	145	2	IPR017897
Domain	TSP_type-3_rpt	THBS1 THBS3	5.89e-04	5	145	2	IPR028974
Domain	-	THBS1 THBS3	5.89e-04	5	145	2	4.10.1080.10
Domain	Thrombospondin_C	THBS1 THBS3	5.89e-04	5	145	2	IPR008859
Domain	TSP_C	THBS1 THBS3	5.89e-04	5	145	2	PF05735
Domain	Thrombospondin_3-like_rpt	THBS1 THBS3	5.89e-04	5	145	2	IPR003367
Domain	TSPN	THBS1 NELL2 THBS3	7.24e-04	23	145	3	SM00210
Domain	RIH_assoc-dom	RYR2 RYR3	8.80e-04	6	145	2	IPR013662
Domain	Pectin_lyas_fold	CEMIP PKHD1	8.80e-04	6	145	2	IPR012334
Domain	-	CEMIP PKHD1	8.80e-04	6	145	2	2.160.20.10
Domain	Ins145_P3_rec	RYR2 RYR3	8.80e-04	6	145	2	PF08709
Domain	RIH_assoc	RYR2 RYR3	8.80e-04	6	145	2	PF08454
Domain	RIH_dom	RYR2 RYR3	8.80e-04	6	145	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	8.80e-04	6	145	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	8.80e-04	6	145	2	IPR015925
Domain	-	RYR2 RYR3	8.80e-04	6	145	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	8.80e-04	6	145	2	PF01365
Domain	-	LRIT2 LRRN1 SLITRK4 LRRC8D LRGUK LRRC31 LMOD1 CD180 TBCE	9.19e-04	321	145	9	3.80.10.10
Domain	CUB_dom	ADGRB3 ZZEF1 CRHBP CSMD1	1.00e-03	57	145	4	IPR000859
Domain	L_dom-like	LRIT2 LRRN1 SLITRK4 LRRC8D LRGUK LRRC31 LMOD1 CD180 TBCE	1.07e-03	328	145	9	IPR032675
Domain	APC_su10/DOC_dom	ZZEF1 HERC2	1.23e-03	7	145	2	IPR004939
Domain	DOC	ZZEF1 HERC2	1.23e-03	7	145	2	PS51284
Domain	ANAPC10	ZZEF1 HERC2	1.23e-03	7	145	2	PF03256
Domain	APC10	ZZEF1 HERC2	1.23e-03	7	145	2	SM01337
Domain	Leu-rich_rpt	LRIT2 LRRN1 SLITRK4 LRRC8D LRGUK LRRC31 CD180 TBCE	1.28e-03	271	145	8	IPR001611
Domain	ARM-type_fold	DCAF1 ZBTB7C HUWE1 LYST RYR3 PACRGL UTP20 HEATR5B IPO11	1.34e-03	339	145	9	IPR016024
Domain	Ank_2	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	1.47e-03	215	145	7	PF12796
Domain	Pectin_lyase_fold/virulence	CEMIP PKHD1	1.63e-03	8	145	2	IPR011050
Domain	K_chnl_volt-dep_Kv1	KCNA5 KCNA7	1.63e-03	8	145	2	IPR003972
Domain	LRR_1	LRIT2 LRRN1 SLITRK4 LRRC8D LRGUK LRRC31 CD180	1.63e-03	219	145	7	PF00560
Domain	Ion_trans_dom	SCN11A RYR2 RYR3 KCNA5 KCNA7	1.96e-03	114	145	5	IPR005821
Domain	Ion_trans	SCN11A RYR2 RYR3 KCNA5 KCNA7	1.96e-03	114	145	5	PF00520
Domain	Ank	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	2.05e-03	228	145	7	PF00023
Domain	Transglut_N	TGM1 TGM7	2.08e-03	9	145	2	PF00868
Domain	TRANSGLUTAMINASES	TGM1 TGM7	2.08e-03	9	145	2	PS00547
Domain	BPI1	BPIFC BPIFB4	2.08e-03	9	145	2	SM00328
Domain	BPI2	BPIFC BPIFB4	2.08e-03	9	145	2	SM00329
Domain	-	TGM1 TGM7	2.08e-03	9	145	2	3.90.260.10
Domain	Gln_gamma-glutamylTfrase_euk	TGM1 TGM7	2.08e-03	9	145	2	IPR023608
Domain	Transglutaminase_AS	TGM1 TGM7	2.08e-03	9	145	2	IPR013808
Domain	Transglutaminase_N	TGM1 TGM7	2.08e-03	9	145	2	IPR001102
Domain	LBP_BPI_CETP	BPIFC BPIFB4	2.08e-03	9	145	2	PS00400
Domain	Transglut_C	TGM1 TGM7	2.08e-03	9	145	2	PF00927
Domain	LBP_BPI_CETP_C	BPIFC BPIFB4	2.59e-03	10	145	2	PF02886
Domain	Transglutaminase_C	TGM1 TGM7	2.59e-03	10	145	2	IPR008958
Domain	Ank_3	ANK1 ANKRD23	2.59e-03	10	145	2	PF13606
Domain	Transglutaminase-like	TGM1 TGM7	3.14e-03	11	145	2	IPR002931
Domain	TGc	TGM1 TGM7	3.14e-03	11	145	2	SM00460
Domain	Transglut_core	TGM1 TGM7	3.14e-03	11	145	2	PF01841
Domain	-	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	3.27e-03	248	145	7	1.25.40.20
Domain	ANK	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	3.50e-03	251	145	7	SM00248
Domain	ANK_REPEAT	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	3.65e-03	253	145	7	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	3.73e-03	254	145	7	IPR020683
Domain	ANK_REP_REGION	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	3.73e-03	254	145	7	PS50297
Domain	ABC_A	ABCA3 ABCA9	3.75e-03	12	145	2	IPR026082
Domain	Lipid-bd_serum_glycop_C	BPIFC BPIFB4	3.75e-03	12	145	2	IPR001124
Domain	G_TR_1	EEFSEC GFM2	4.41e-03	13	145	2	PS00301
Domain	-	ACAD9 ACOX1	4.41e-03	13	145	2	1.10.540.10
Domain	LBP_BPI_CETP	BPIFC BPIFB4	4.41e-03	13	145	2	PF01273
Domain	AcylCoA_DH/ox_N	ACAD9 ACOX1	4.41e-03	13	145	2	IPR013786
Domain	BPI/LBP/Plunc	BPIFC BPIFB4	4.41e-03	13	145	2	IPR032942
Domain	Bactericidal_perm-incr_a/b_dom	BPIFC BPIFB4	4.41e-03	13	145	2	IPR017943
Domain	Lipid-bd_serum_glycop_N	BPIFC BPIFB4	4.41e-03	13	145	2	IPR017942
Domain	Ankyrin_rpt	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	4.42e-03	262	145	7	IPR002110
Domain	EGF_CA	THBS1 NELL2 THBS3 HEG1	4.52e-03	86	145	4	PF07645
Domain	LRR	LRIT2 LRRN1 SLITRK4 LRRC8D LRGUK CD180	4.87e-03	201	145	6	PS51450
Domain	WH2	COBL LMOD1	5.12e-03	14	145	2	SM00246
Domain	Cys-rich_flank_reg_C	LRIT2 LRRN1 SLITRK4 CD180	5.32e-03	90	145	4	IPR000483
Domain	LRRCT	LRIT2 LRRN1 SLITRK4 CD180	5.32e-03	90	145	4	SM00082
Domain	FERM_M	FRMPD4 PTPN13 MYO15A	5.45e-03	46	145	3	PF00373
Domain	-	LRIT2 TRIM2 LRRN1 DSCAM MXRA8 ADAMTSL3 TGM1 CD3G TRIM67 PKHD1 TGM7 CDON	5.59e-03	663	145	12	2.60.40.10
Domain	Bbox_C	TRIM2 TRIM67	5.88e-03	15	145	2	IPR003649
Domain	Acyl-CoA_Oxase/DH_cen-dom	ACAD9 ACOX1	5.88e-03	15	145	2	IPR006091
Domain	BBC	TRIM2 TRIM67	5.88e-03	15	145	2	SM00502
Domain	AcylCoA_DH/oxidase_NM_dom	ACAD9 ACOX1	5.88e-03	15	145	2	IPR009100
Domain	Acyl-CoA_dh_M	ACAD9 ACOX1	5.88e-03	15	145	2	PF02770
Domain	FERM_central	FRMPD4 PTPN13 MYO15A	6.50e-03	49	145	3	IPR019748
Domain	FERM_domain	FRMPD4 PTPN13 MYO15A	6.50e-03	49	145	3	IPR000299
Domain	WH2	COBL LMOD1	6.69e-03	16	145	2	PF02205
Domain	AcylCo_DH/oxidase_C	ACAD9 ACOX1	6.69e-03	16	145	2	IPR009075
Domain	FERM_1	FRMPD4 PTPN13 MYO15A	6.88e-03	50	145	3	PS00660
Domain	FERM_2	FRMPD4 PTPN13 MYO15A	6.88e-03	50	145	3	PS00661
Domain	FERM_3	FRMPD4 PTPN13 MYO15A	6.88e-03	50	145	3	PS50057
Domain	Band_41_domain	FRMPD4 PTPN13 MYO15A	6.88e-03	50	145	3	IPR019749
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CUL1 ANK1 ACACB RSL1D1 ACAD9 SLITRK4 RYR3 MDN1 MTHFD1 USP32 COBL CDK11B IPO11 DCAF7	4.09e-08	497	151	14	36774506
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	CCP110 RSL1D1 ACAD9 TARS2 NUP54 PTPN13 IGF2R MDN1 OCIAD1 UTP20 HERC2 YIPF6 IPO11 DCAF7	5.76e-06	754	151	14	33060197
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	DIP2B RSL1D1 ADGRB3 VPS16 INO80 FCHO2 THBS1 GPR158 EIF2B2 HERC2 SNRPD1	7.94e-06	475	151	11	31040226
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	EEFSEC CEP295NL RYR2 RYR3 PTPN13 PNPLA3 SOWAHB	9.32e-06	168	151	7	30631154
Pubmed	Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.	GCKR PNPLA3	1.87e-05	2	151	2	23800943
Pubmed	Cleavage of the CD11b extracellular domain by the leukocyte serprocidins is critical for neutrophil detachment during chemotaxis.	ITGAM LYST	1.87e-05	2	151	2	21403131
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	1.87e-05	2	151	2	8898078
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	1.87e-05	2	151	2	14550562
Pubmed	Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3.	THBS1 THBS3	1.87e-05	2	151	2	8654563
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	1.87e-05	2	151	2	21531043
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	1.87e-05	2	151	2	16678258
Pubmed	Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage.	HUWE1 CDC6	1.87e-05	2	151	2	17567951
Pubmed	Genetic Epidemiology and Clinical Features of Hereditary Hearing Impairment in the Taiwanese Population.	GJB2 MYO15A	1.87e-05	2	151	2	31581539
Pubmed	Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.	GCKR PNPLA3	1.87e-05	2	151	2	24477042
Pubmed	Thrombospondin 3 is a developmentally regulated heparin binding protein.	THBS1 THBS3	1.87e-05	2	151	2	8288588
Pubmed	Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein.	UBQLN4 ATXN1	1.87e-05	2	151	2	11001934
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	1.87e-05	2	151	2	14985349
Pubmed	Purification and assay of the human INO80 and SRCAP chromatin remodeling complexes.	INO80 SRCAP	1.87e-05	2	151	2	17101442
Pubmed	Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.	GCKR PNPLA3	1.87e-05	2	151	2	22105854
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	ACOX1 HUWE1 YARS2 MDN1 HERC2	2.08e-05	76	151	5	27542412
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DIP2B CCP110 KIF26B PRAG1 LYST FAM171A1 PTPN13 MDN1 KCNA7 ATXN1 SYNE2 MIEF1 COBL DCAF7	2.52e-05	861	151	14	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DIP2B INTU LRRN1 HUWE1 ZSWIM1 TARS2 LRRC8D JMJD1C KANSL3 PTPN13 SMG7 ATXN1 GPR158 NAT10 PIP5K1A COBL CSMD1 NXPH4 INVS	2.62e-05	1489	151	19	28611215
Pubmed	Genetic and physical delineation of the region overlapping the progressive motor neuropathy (pmn) locus on mouse chromosome 13.	LYST RYR2 TBCE	2.82e-05	14	151	3	11472062
Pubmed	FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.	RSL1D1 VPS16 IGF2R USP32 UTP20 CDK11B TBCE	4.16e-05	212	151	7	33462405
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RSL1D1 HUWE1 SRCAP NUP54 NOP58 IGF2R MDN1 RPAP1 MTHFD1 SYNE2 NAT10 UTP20 HERC2 HEATR5B SNRPD1	4.26e-05	1024	151	15	24711643
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	RSL1D1 INO80 SRCAP NOP58 IGF2R MTHFD1 SNRPD1 IPO11	5.34e-05	300	151	8	28561026
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	5.60e-05	3	151	2	18403125
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	5.60e-05	3	151	2	29730765
Pubmed	Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.	GCKR PNPLA3	5.60e-05	3	151	2	24785259
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR2 RYR3	5.60e-05	3	151	2	7876312
Pubmed	Organization and expression of the SLC36 cluster of amino acid transporter genes.	SLC36A1 SLC36A3	5.60e-05	3	151	2	15058382
Pubmed	A cluster of proton/amino acid transporter genes in the human and mouse genomes.	SLC36A1 SLC36A3	5.60e-05	3	151	2	12809675
Pubmed	Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.	GCKR PNPLA3	5.60e-05	3	151	2	27015186
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR2 RYR3	5.60e-05	3	151	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR2 RYR3	5.60e-05	3	151	2	10788707
Pubmed	mRNA Expression of thrombospondin 1, 2 and 3 from proximal to distal in human abdominal aortic aneurysm - preliminary report.	THBS1 THBS3	5.60e-05	3	151	2	34669362
Pubmed	Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers.	THBS1 THBS3	5.60e-05	3	151	2	1459996
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR2 RYR3	5.60e-05	3	151	2	7621815
Pubmed	Differential expression of thrombospondin 1, 2, and 3 during murine development.	THBS1 THBS3	5.60e-05	3	151	2	8400410
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR2 RYR3	5.60e-05	3	151	2	10473538
Pubmed	The relationship among GNB3 rs5443, PNPLA3 rs738409, GCKR rs780094 gene polymorphisms, type of maternal gestational weight gain and neonatal outcomes (STROBE-compliant article).	GCKR PNPLA3	5.60e-05	3	151	2	31305457
Pubmed	Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system.	THBS1 THBS3	5.60e-05	3	151	2	9373030
Pubmed	Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.	THBS1 IPO11	5.60e-05	3	151	2	29602637
Pubmed	Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.	LYST THBS1	5.60e-05	3	151	2	18757424
Pubmed	Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.	GCKR PNPLA3	5.60e-05	3	151	2	28436986
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR2 RYR3	5.60e-05	3	151	2	18434746
Pubmed	Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes.	ANK1 LRRN1	5.60e-05	3	151	2	38862513
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR2 RYR3	5.60e-05	3	151	2	9204703
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR2 RYR3	5.60e-05	3	151	2	21881589
Pubmed	Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.	GCKR PNPLA3	5.60e-05	3	151	2	31255630
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR2 RYR3	5.60e-05	3	151	2	12213830
Pubmed	Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin.	GCKR PNPLA3	5.60e-05	3	151	2	39042259
Pubmed	Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.	GCKR PNPLA3	5.60e-05	3	151	2	23416328
Pubmed	CircTHBS1 promotes trophoblast cell migration and invasion and inhibits trophoblast apoptosis by regulating miR-136-3p/IGF2R axis.	THBS1 IGF2R	5.60e-05	3	151	2	38581244
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR2 RYR3	5.60e-05	3	151	2	9242641
Pubmed	RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle.	RYR2 RYR3	5.60e-05	3	151	2	15024040
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR2 RYR3	5.60e-05	3	151	2	25239916
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR2 RYR3	5.60e-05	3	151	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR2 RYR3	5.60e-05	3	151	2	11159936
Pubmed	Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity.	GCKR PNPLA3	5.60e-05	3	151	2	30710115
Pubmed	Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.	GCKR PNPLA3	5.60e-05	3	151	2	29493856
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR2 RYR3	5.60e-05	3	151	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR2 RYR3	5.60e-05	3	151	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR2 RYR3	5.60e-05	3	151	2	7635066
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CUL1 KNTC1 RSL1D1 ACAD9 EEF1E1 HUWE1 FCHO2 HPSE GFM2 NOP58 MDN1 SYNE2 NAT10 EIF2B2 SDF2L1 COBL SNRPD1 IPO11	5.66e-05	1440	151	18	30833792
Pubmed	HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.	DCAF1 NUP54 GTF2H1	7.39e-05	19	151	3	21489275
Pubmed	The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.	CUL1 DIP2B TARS2 NOP58 MDN1 MTHFD1 NAT10	8.38e-05	237	151	7	29564676
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DCAF1 RSL1D1 ACAD9 TARS2 FAM171A1 NOP58 PTPN13 IGF2R MDN1 OCIAD1 RPAP1 SYNE2 NAT10 SDF2L1 PIP5K1A HERC2 ANKRD52 DCAF7	8.51e-05	1487	151	18	33957083
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	INTU INO80 ADAMTSL3 CEMIP HEG1	8.97e-05	103	151	5	10574462
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	CUL1 MTIF3 DIP2B RSL1D1 ACAD9 HUWE1 TARS2 ZZEF1 GFM2 YARS2 NOP58 MDN1 OCIAD1 RPAP1 SYNE2 NAT10 MIEF1 HERC2	9.18e-05	1496	151	18	32877691
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	FRMPD4 HUWE1 SRCAP MDN1 HERC2	9.39e-05	104	151	5	9205841
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ANK1 KIF26B HUWE1 ZZEF1 MDN1 RPAP1 EDAR MTHFD1 AGTR2 PKHD1 UTP20 SERPINA9	9.50e-05	736	151	12	29676528
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DCAF1 ACACB TARS2 JMJD1C SMG7 PIP5K1A CDC6	9.55e-05	242	151	7	34011540
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	INO80 HUWE1 SRCAP ZZEF1 PRAG1 LYST KANSL3 TLNRD1 HEG1 IGF2R MDN1 RPAP1 COBL HERC2 SOWAHB	9.95e-05	1105	151	15	35748872
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	DCAF1 RSL1D1 HUWE1 JMJD1C YARS2 NUP54 NOP58 GTF2H1 MDN1 MTHFD1 NAT10 UTP20 CDK11B DCAF7	1.11e-04	989	151	14	36424410
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR2 RYR3	1.12e-04	4	151	2	23413940
Pubmed	EHD1 promotes CP110 ubiquitination by centriolar satellite delivery of HERC2 to the mother centriole.	CCP110 HERC2	1.12e-04	4	151	2	37074924
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR2 RYR3	1.12e-04	4	151	2	9607712
Pubmed	Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets.	THBS1 THBS3	1.12e-04	4	151	2	6338048
Pubmed	The physical and genetic map surrounding the Lyst gene on mouse chromosome 13.	LYST RYR2	1.12e-04	4	151	2	9070932
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR2 RYR3	1.12e-04	4	151	2	23482488
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR2 RYR3	1.12e-04	4	151	2	18206662
Pubmed	Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.	GCKR PNPLA3	1.12e-04	4	151	2	27752939
Pubmed	Heterogeneity of Hereditary Hearing Loss in Iran: a Comprehensive Review.	GJB2 MYO15A	1.12e-04	4	151	2	27743438
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR2 RYR3	1.12e-04	4	151	2	9384575
Pubmed	NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.	GCKR PNPLA3	1.12e-04	4	151	2	29648650
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	VPS16 INO80 NOP58 NAA25 GTF2H1 PTPN13 MDN1 NAT10 HERC2 IPO11	1.20e-04	533	151	10	30554943
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	DIP2B HUWE1 ITGAM MDN1 MTHFD1 SDF2L1 SNRPD1 IPO11	1.38e-04	344	151	8	30333137
Pubmed	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.	CUL1 EEFSEC RSL1D1 MDN1 MTHFD1 NAT10 UTP20	1.56e-04	262	151	7	36880596
Pubmed	UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover.	DCAF1 CUL1 HUWE1 DCAF7	1.57e-04	62	151	4	18775313
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	MTIF3 DSCAM ADGRB3 PTPN13 IGF2R COBL CSMD1	1.67e-04	265	151	7	19240061
Pubmed	Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.	THBS1 THBS3	1.86e-04	5	151	2	30622267
Pubmed	Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: role of receptor internalization, thrombospondin-1, and alpha(v)beta3.	TBXA2R THBS1	1.86e-04	5	151	2	14963009
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR2 RYR3	1.86e-04	5	151	2	23918386
Pubmed	Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen.	THBS1 THBS3	1.86e-04	5	151	2	18467703
Pubmed	Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control.	CUL1 CDC6	1.86e-04	5	151	2	25557911
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR2 RYR3	1.86e-04	5	151	2	19011160
Pubmed	Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.	RYR2 RYR3	1.86e-04	5	151	2	33060591
Pubmed	Genetic Associations with Gestational Duration and Spontaneous Preterm Birth.	EEFSEC AGTR2	1.86e-04	5	151	2	28877031
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	DCAF1 CUL1 RSL1D1 ACAD9 EEF1E1 HUWE1 TARS2 YARS2 RPAP1 MTHFD1 WDR87 EIF2B2 PIP5K1A PIPSL SNRPD1 DCAF7	2.40e-04	1335	151	16	29229926
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	7.83e-05	3	93	2	287
GeneFamily	Ankyrin repeat domain containing	ANKRD29 ANK1 ANKRD23 POTEJ ANKRD52 SOWAHB INVS	2.52e-04	242	93	7	403
GeneFamily	Transglutaminases	TGM1 TGM7	9.20e-04	9	93	2	773
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	LRIT2 LRRN1 DSCAM ADAMTSL3 CDON	1.46e-03	161	93	5	593
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMPD4 PTPN13 MYO15A	2.17e-03	50	93	3	1293
GeneFamily	ATP binding cassette subfamily A	ABCA3 ABCA9	2.29e-03	14	93	2	805
GeneFamily	BPI fold containing	BPIFC BPIFB4	3.00e-03	16	93	2	456
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF1 DCAF7	3.80e-03	18	93	2	498
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	ZZEF1 HERC2	3.80e-03	18	93	2	91
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	INTU LRRN1 RSL1D1 SLITRK4 ADGRB3 LRRC8D NUP54 NELL2 NOP58 NAA25 HEG1 ZNF605 SMG7 SYNE2 NAT10 ZNF624 UTP20 CDK11B CDC6 IPO11	1.81e-05	989	148	20	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	RSL1D1 NUP54 NAA25 SMG7 NAT10 ZNF624 UTP20 CDC6	2.50e-05	169	148	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ANK1 KIF26B RYR2 RYR3 PKHD1 CSMD1 MYO15A	2.15e-07	184	150	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ANK1 KIF26B RYR2 RYR3 PKHD1 CSMD1 MYO15A	2.15e-07	184	150	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ANK1 KIF26B RYR2 RYR3 PKHD1 CSMD1 MYO15A	2.15e-07	184	150	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FRMPD4 ADGRB3 ADAMTSL3 ABCA9 RYR3 KCNA5 CDON	1.16e-06	159	150	7	f376bf6cd0ed374211edac3c384f3a78f0caef2a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP1 RGS3 SLC47A2 EDAR SYNE2 PKHD1 COBL	3.29e-06	186	150	7	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 GRIN3A	4.20e-06	193	150	7	c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 GRIN3A	4.35e-06	194	150	7	83863da11dfbe59b2d0a2c08db40b537c150588c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRB3 PKD1L3 RYR3 TRIM67 CSMD1 MYO15A CDON	4.50e-06	195	150	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRB3 PKD1L3 RYR3 TRIM67 CSMD1 MYO15A CDON	4.50e-06	195	150	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KIF26B MXRA8 ADGRB3 ABCA9 RYR2 CEMIP THBS1	4.97e-06	198	150	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	CD8+_Memory_T_cell-CV-2\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	RSL1D1 EEF1E1 NOP58 MTHFD1 SDF2L1 CDC6 SNRPD1	5.14e-06	199	150	7	1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8
ToppCell	CV-Moderate-2\|Moderate / Virus stimulation, Condition and Cluster	RSL1D1 EEF1E1 NOP58 MTHFD1 SDF2L1 CDC6 SNRPD1	5.14e-06	199	150	7	70d6f2a328eec4cb2cecb7cd85859fba9e15c9c8
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 SLC24A4	5.31e-06	200	150	7	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 GRIN3A	5.31e-06	200	150	7	6a44439e4a7ce3627271375b04cfcfb9467218f4
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 SLC24A4	5.31e-06	200	150	7	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 GRIN3A	5.31e-06	200	150	7	8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 SLC24A4	5.31e-06	200	150	7	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP HEG1 TRIM67 GRIN3A	5.31e-06	200	150	7	cb1f4b0d66da5b0466ff17b29e7034d451d93e4f
ToppCell	facs-Heart-RV-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 DSCAM LRGUK PKHD1 MYO15A SERPINA9	1.73e-05	160	150	6	41d6c811c445c0ba9b6a2deb10a3b6b793172582
ToppCell	facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 DSCAM LRGUK PKHD1 MYO15A SERPINA9	1.73e-05	160	150	6	c1d03c0ac9c12615a06499209fcdf18e9b6f1fba
ToppCell	COVID-CD8-CD8_2\|COVID / Condition, Cell_class and T cell subcluster	RYR2 NELL2 CD3G SYNE2 SHOC1 ANKRD52	1.79e-05	161	150	6	307dcc17475413cd9eb70c27bc447f938ee5723d
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma\|TCGA-Brain / Sample_Type by Project: Shred V9	LRIT2 ANK1 RGR TRIM67 GPR158 GRIN3A	1.79e-05	161	150	6	5f6b2d7f80a8ee16651e304481d2da3fae313824
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	ACOX1 TARS2 TGM1 PIP5K1A CDK11B HEATR5B	2.27e-05	168	150	6	8697b40b2ec2cce68ef3beb4792eb3eff29be053
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPSE RGS3 LRRC9 HEG1 PTCH2 PNPLA3	2.59e-05	172	150	6	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPSE RGS3 LRRC9 HEG1 PTCH2 PNPLA3	2.59e-05	172	150	6	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCHO2 LYST JMJD1C ABCA9 RYR2 HEG1	2.95e-05	176	150	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL3 ABCA9 RYR2 NELL2 LMOD1 PLIN1	3.05e-05	177	150	6	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL3 ABCA9 RYR2 NELL2 LMOD1 PLIN1	3.05e-05	177	150	6	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BPIFC HPSE IL23A SLC47A2 GJB2 SERPINA9	3.35e-05	180	150	6	18bf8561ad3aa9787d2a8ef942a96f641734c608
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ANKRD29 KNTC1 DSCAM TGM1 HEG1 SHOC1	3.79e-05	184	150	6	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B CRHBP TRIM67 PKHD1 GRIN3A	3.79e-05	184	150	6	7f6c8912677764d438ab0555faca344d74c2f483
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ANKRD29 KNTC1 DSCAM TGM1 HEG1 SHOC1	3.79e-05	184	150	6	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANKRD29 ZBTB7C BRINP1 PRAG1 NELL2 SLC24A4	3.79e-05	184	150	6	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	3.79e-05	184	150	6	23515c28e1f42aab29cef9e5b4a7f45bda7f5520
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	ZBTB7C UBQLN4 HPSE LYST IGF2R SOWAHB	3.79e-05	184	150	6	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JMJD1C RYR2 THBS1 C18orf63 PKHD1 CSMD1	4.02e-05	186	150	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B CRHBP HEG1 TRIM67 GRIN3A	4.02e-05	186	150	6	96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCHO2 LYST RGS3 HEG1 SYNE2 IPO11	4.02e-05	186	150	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B CRHBP TRIM67 PKHD1 GRIN3A	4.14e-05	187	150	6	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB7C ADAMTSL3 ABCA9 LMOD1 GRIN3A CDON	4.27e-05	188	150	6	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB7C ADAMTSL3 ABCA9 LMOD1 GRIN3A CDON	4.53e-05	190	150	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGAM HPSE LYST THBS1 SLC24A4 PTCH2	4.66e-05	191	150	6	5d6ef70cc15ec5e983a953e547e40f9c06e355fb
ToppCell	COPD-Lymphoid-T\|World / Disease state, Lineage and Cell class	RYR2 NELL2 NOP58 CD3G ATXN1 SYNE2	4.80e-05	192	150	6	eb4909574fb5fc91399463523e2737095773200a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	4.94e-05	193	150	6	d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	4.94e-05	193	150	6	010717ca052b6c8a525a43aaeffddea0d1113e63
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B CRHBP HEG1 TRIM67 GRIN3A	4.94e-05	193	150	6	2189da4b727e25e62669d7b9257f06493be21a27
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FRMPD4 KIF26B ADAMTSL3 PRAG1 EDAR LMOD1	4.94e-05	193	150	6	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	4.94e-05	193	150	6	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	4.94e-05	193	150	6	e74fdc8718fe0933e1f4dd3fe37e2134983b99b6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	4.94e-05	193	150	6	658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KNTC1 KIF26B PRAG1 EDAR CENPI CDC6	5.08e-05	194	150	6	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	5.08e-05	194	150	6	1bcb3fafd498614f7bac2b1c9b7de56e39110f65
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FRMPD4 KIF26B ADAMTSL3 PRAG1 EDAR LMOD1	5.08e-05	194	150	6	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	CV-Severe-2\|CV / Virus stimulation, Condition and Cluster	RSL1D1 EEF1E1 NOP58 MTHFD1 SDF2L1 SNRPD1	5.23e-05	195	150	6	1cde7f6e6c9c610bacc79014519447112c27dd9d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 DSCAM BRINP1 RYR2 NELL2 CSMD1	5.23e-05	195	150	6	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	RYR2 NELL2 NOP58 CD3G ATXN1 SYNE2	5.38e-05	196	150	6	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANKRD29 ABCA3 PTPN13 SYNE2 PKHD1 COBL	5.53e-05	197	150	6	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THBS1 THBS3 TRIM67 KCNA5 TIMP4 LMOD1	5.53e-05	197	150	6	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	KIF26B ADGRB3 ABCA9 RYR2 CEMIP THBS1	5.53e-05	197	150	6	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DCAF1 ADAMTSL3 ITGAM JMJD1C HEG1 CD180	5.69e-05	198	150	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK1 RYR2 THBS1 GJB2 KCNA5 LMOD1	5.69e-05	198	150	6	f261a37dd07976548b897af86df1d1a0dc069889
ToppCell	CV-Severe-2\|Severe / Virus stimulation, Condition and Cluster	RSL1D1 EEF1E1 NOP58 MTHFD1 SDF2L1 SNRPD1	5.69e-05	198	150	6	254659bb53dc2511c714295c2df1ab1fddb2f867
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 ADGRB3 BRINP1 RYR2 NELL2 CSMD1	5.69e-05	198	150	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	MXRA8 ADGRB3 ADAMTSL3 ABCA9 RYR2 LMOD1	5.69e-05	198	150	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DCAF1 ADAMTSL3 ITGAM JMJD1C HEG1 CD180	5.69e-05	198	150	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	Sepsis-URO-Lymphocyte-T/NK-CD8+_T_naive\|URO / Disease, condition lineage and cell class	ANKRD29 ACACB RSL1D1 NELL2 CD3G CDON	5.69e-05	198	150	6	c07426d4119b53e58eb5f448ae364f47cac1fc5c
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DCAF1 ADAMTSL3 ITGAM JMJD1C HEG1 CD180	5.69e-05	198	150	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ITGAM THBS1 IGF2R SLC24A4 USP32 CD180	5.85e-05	199	150	6	4e0b73d88b1345ec63a9e5629762341e75beb47f
ToppCell	CV-Moderate-2\|CV / Virus stimulation, Condition and Cluster	RSL1D1 EEF1E1 NOP58 MTHFD1 CDC6 SNRPD1	5.85e-05	199	150	6	2d98424a5247e87f98095c11fb945289092a9d75
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	6.02e-05	200	150	6	858421b91f5207b7934b5c219752cb9322a3da31
ToppCell	Neuronal-Inhibitory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B CRHBP HEG1 TRIM67 GRIN3A	6.02e-05	200	150	6	9ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	6.02e-05	200	150	6	a7022762c1d8aedb7b3e9605873b1e68b9907b35
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 ZBTB7C DSCAM MXRA8 RGR PTPN13	6.02e-05	200	150	6	f7c3a8f5ac156c05ad7335d6d142c154c7d86449
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B CRHBP HEG1 TRIM67 GRIN3A	6.02e-05	200	150	6	347a510755374c6a66acee326565dfc447993f18
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Neuron\|5w / Sample Type, Dataset, Time_group, and Cell type.	LRRN1 ZZEF1 CRHBP PTCH2 GRIN3A NXPH4	6.02e-05	200	150	6	6f3fe94107fa2a2ded4888780b36700cce48adb7
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANK1 KIF26B ADAMTSL3 CRHBP TRIM67 GRIN3A	6.02e-05	200	150	6	2131c8e7fa054b79906eaf60536da892438b09cd
ToppCell	COVID-19-kidney-Epithelial_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BANF2 CRHBP RYR3 GPR158 PKHD1	8.79e-05	133	150	5	a8abb6b54862123961ae6defbf251ee6e9575258
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5\|TCGA-Brain / Sample_Type by Project: Shred V9	LRIT2 RGR TRIM67 SLC24A4 GRIN3A	1.01e-04	137	150	5	a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5
ToppCell	Control-Epithelial_alveolar-AT_1-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD29 LRRN1 LRRC9 TGM1 COBL	1.20e-04	142	150	5	94e277f038f4006d99ff50222b0f5cf89bc3d46d
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCAF1 LRRN1 THBS1 MYO15A PLIN1	1.20e-04	142	150	5	d52da766e031f7409eb5a7a9fa88f48e14a79d8b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCAF1 LRRN1 THBS1 MYO15A PLIN1	1.20e-04	142	150	5	a05b320cf182b2aaf18df7c40045dc65b659bf20
ToppCell	ASK454-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	JMJD1C GTF2H1 ZNF605 USP32 UTP20	1.28e-04	144	150	5	8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KNTC1 EDAR WDR87 CENPI CDC6	1.70e-04	153	150	5	d7635f3d4831c02a94f53afc674847d5b51453be
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KNTC1 EDAR WDR87 CENPI CDC6	1.70e-04	153	150	5	54a941950bbb848077c7bd5726da9e4b3244bd38
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KNTC1 EDAR WDR87 CENPI CDC6	1.70e-04	153	150	5	69a8550418ba0fc908a84b3b85761abb6e8ca4c0
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KNTC1 EDAR WDR87 CENPI CDC6	1.70e-04	153	150	5	e50d20f9e553b8c3e10e187770d8abe1a43d109e
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Efhd2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RGR EDAR WDR87 CDC6	1.70e-04	82	150	4	93b75f8822ffe8870195cd1fe0a7286478f61e79
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM H1-7 PRAG1 CD3G CDON	1.80e-04	155	150	5	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Monocytes\|Myeloid_cells / Location, Cell class and cell subclass	SLITRK4 MXRA8 NELL2 GJB2 PIP5K1A	1.80e-04	155	150	5	85eb60d285b8bfc095c341ae90c0e3b7e7dca9c1
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM H1-7 PRAG1 CD3G CDON	1.80e-04	155	150	5	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|390C / Donor, Lineage, Cell class and subclass (all cells)	GJB2 SMG7 TIMP4 ZNF624 CD180	1.80e-04	155	150	5	15bacd06cc2b02b13c85bb71c5b758e5ff613e80
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EEFSEC CCP110 ANK1 ADGRB3 RYR3	1.86e-04	156	150	5	895927228c93cd090303984c5be6ebfb59ed6f3a
ToppCell	BAL-Severe-cDC_4\|Severe / Compartment, Disease Groups and Clusters	ZBTB7C ACACB IL23A ZNF624 CSMD1	1.97e-04	158	150	5	73f66689ef59f71b14cb7141ca5951cc47fe57c1
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	ACACB FPGT PKD1L3 KANSL3 COBL	2.09e-04	160	150	5	d288b0a315f6adc0be4bdc89fa67bf93679a743f
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF26B CEP295NL ITGAM LYST SLC24A4	2.15e-04	161	150	5	3a5f2877e3b29463a3a6da05009b0ab8747b4c47
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK1 SYNE2 CD180 SERPINA9 MAP4K2	2.21e-04	162	150	5	3e15b3e97a2ade86d0cb0ab15fccb9a2e2e27dd4
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ACACB DSCAM RYR3 CENPI	2.27e-04	163	150	5	b83a35c4426d66b5734a98fa6c72b345fe462030
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ACACB DSCAM RYR3 CENPI	2.27e-04	163	150	5	c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM RGR ABCA9 RYR2 CSMD1	2.41e-04	165	150	5	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM RGR ABCA9 RYR2 CSMD1	2.41e-04	165	150	5	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TRIM2 ACACB DSCAM GCKR SRCAP ITGAM CEMIP ATXN1 CDON	2.46e-06	177	148	9	4164_UP
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	7.27e-05	3	146	2	DOID:3529 (implicated_via_orthology)
Disease	lung adenocarcinoma (implicated_via_orthology)	GJB2 IGF2R	7.27e-05	3	146	2	DOID:3910 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	7.27e-05	3	146	2	DOID:8545 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in large VLDL percentage	BANF2 GCKR JMJD1C PNPLA3	1.73e-04	56	146	4	EFO_0022250
Disease	low density lipoprotein particle size measurement	BANF2 GCKR NAA25 PNPLA3	1.98e-04	58	146	4	EFO_0008593
Disease	fibrinogen measurement, factor VII measurement	DIP2B GCKR PKD1L3 JMJD1C	1.98e-04	58	146	4	EFO_0004619, EFO_0004623
Disease	skin aging measurement	PKD1L3 SLC24A4 EDAR SYNE2 EIF2B2 SLC36A3	2.92e-04	181	146	6	EFO_0008006
Disease	2-myristoyl-GPC (14:0) measurement	GCKR SNRPD1	3.60e-04	6	146	2	EFO_0800242
Disease	1-myristoyl-GPC (14:0) measurement	GCKR SNRPD1	3.60e-04	6	146	2	EFO_0800221
Disease	creatinine measurement	EEFSEC INTU DSCAM KIF26B GCKR INO80 PKD1L3 SLC47A2 CEMIP THBS3 IGF2R USP32 PKHD1 PIP5K1A	4.38e-04	995	146	14	EFO_0004518
Disease	tea consumption measurement	RGS3 NAA25 SLC35D3 PKHD1 CSMD1	4.66e-04	129	146	5	EFO_0010091
Disease	urate measurement	UBQLN4 GCKR JMJD1C CEMIP THBS1 NOP58 THBS3 NAA25 PKHD1 PNPLA3 HEATR5B ANKRD52 MAP4K2	5.25e-04	895	146	13	EFO_0004531
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ACACB BANF2 GCKR JMJD1C IGF2R SYNE2 PNPLA3	6.38e-04	291	146	7	EFO_0008317, EFO_0020946
Disease	visceral adipose tissue measurement	KNTC1 SCN11A UBQLN4 PKD1L3 ZZEF1 HEG1 ATXN1 GPR158 PKHD1	6.81e-04	481	146	9	EFO_0004765
Disease	chronic kidney disease, diabetic nephropathy	EEF1E1 PTPN13 SLC24A4	7.52e-04	36	146	3	EFO_0000401, EFO_0003884
Disease	response to lamotrigine	GRIN3A CSMD1	8.56e-04	9	146	2	EFO_0007661
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	BANF2 GCKR ITGAM JMJD1C IGF2R SYNE2	8.57e-04	222	146	6	EFO_0008317, EFO_0020943
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	BANF2 GCKR ITGAM JMJD1C IGF2R PNPLA3	9.19e-04	225	146	6	EFO_0008317, EFO_0020947
Disease	uric acid measurement	INTU DSCAM BANF2 GCKR CEMIP NAA25 PNPLA3 ANKRD52 MAP4K2 IPO11	9.51e-04	610	146	10	EFO_0004761
Disease	cholelithiasis	GCKR FCHO2 JMJD1C PNPLA3	9.72e-04	88	146	4	EFO_0004799
Disease	FEV/FEC ratio	EEFSEC ABCA3 BANF2 EEF1E1 BRINP1 ADAMTSL3 JMJD1C NELL2 THBS3 RPAP1 SYNE2 LMOD1 CSMD1 MYO15A CDON	1.16e-03	1228	146	15	EFO_0004713
Disease	hemoglobin A1 measurement	DCAF1 ZBTB7C ANK1 GCKR JMJD1C THBS3 NAA25 SYNE2 MAP4K2	1.17e-03	520	146	9	EFO_0007629
Disease	triglycerides in large LDL measurement	GCKR IGF2R SYNE2	1.27e-03	43	146	3	EFO_0022319
Disease	pigmentation disease (is_implicated_in)	SLC24A4 HERC2	1.30e-03	11	146	2	DOID:10123 (is_implicated_in)
Disease	Diabetic Cardiomyopathies	RYR2 AGTR2	1.30e-03	11	146	2	C0853897
Disease	level of Ceramide (d40:1) in blood serum	GCKR SYNE2	1.30e-03	11	146	2	OBA_2045185
Disease	pro‐interleukin‐16 measurement	ADAMTSL3 SLC24A4	1.30e-03	11	146	2	EFO_0010629
Disease	coffee consumption measurement, tea consumption measurement	GCKR JMJD1C SLC35D3	1.35e-03	44	146	3	EFO_0006781, EFO_0010091
Disease	glutamine measurement	GCKR GTF2H1 SLC36A3 PNPLA3	1.40e-03	97	146	4	EFO_0009768
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	ACACB GCKR IGF2R SYNE2 MAP4K2	1.45e-03	166	146	5	EFO_0004530, EFO_0004611
Disease	fibrinogen measurement, tissue plasminogen activator measurement	DIP2B PKD1L3 JMJD1C	1.45e-03	45	146	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	DIP2B PKD1L3 JMJD1C	1.45e-03	45	146	3	EFO_0004623, EFO_0004792
Disease	cholesterol to total lipids in large VLDL percentage	BANF2 GCKR JMJD1C	1.45e-03	45	146	3	EFO_0022236
Disease	fatty acid measurement	ACACB GCKR PRAG1 JMJD1C NAA25 IGF2R PNPLA3 MAP4K2	1.53e-03	436	146	8	EFO_0005110
Disease	hair colour measurement, hair morphology measurement	SLC24A4 HERC2	1.55e-03	12	146	2	EFO_0007821, EFO_0007822
Disease	triacylglycerol 44:1 measurement	DSCAM CSMD1	1.55e-03	12	146	2	EFO_0010399
Disease	level of Phosphatidylcholine (14:0_18:1) in blood serum	GCKR SNRPD1	1.55e-03	12	146	2	OBA_2045062
Disease	non-alcoholic steatohepatitis	GCKR PNPLA3	1.55e-03	12	146	2	EFO_1001249
Disease	alpha fetoprotein measurement	GCKR JMJD1C PNPLA3 SERPINA9	1.56e-03	100	146	4	EFO_0010583
Disease	Drugs used in diabetes use measurement	MTIF3 ANK1 GCKR ZZEF1 JMJD1C RPAP1	1.74e-03	255	146	6	EFO_0009924
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	GCKR JMJD1C SYNE2 PNPLA3	1.74e-03	103	146	4	EFO_0008595, EFO_0020944
Disease	sodium measurement	BRINP1 GCKR JMJD1C PKHD1	1.74e-03	103	146	4	EFO_0009282
Disease	squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma	PKHD1 CSMD1	1.83e-03	13	146	2	EFO_0000707, EFO_0004193, EFO_0007932
Disease	Mental Retardation, X-Linked Nonsyndromic	HUWE1 AGTR2	1.83e-03	13	146	2	C3501611
Disease	cholesteryl esters to total lipids in small VLDL percentage	BANF2 GCKR JMJD1C	1.85e-03	49	146	3	EFO_0022256
Disease	cognitive function measurement	KNTC1 FRMPD4 DSCAM EEF1E1 BRINP1 FPGT PKD1L3 ADAMTSL3 JMJD1C RGS3 RYR3 CEMIP ATXN1 PKHD1 SOWAHB TBCE	2.02e-03	1434	146	16	EFO_0008354
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	BANF2 GCKR JMJD1C IGF2R SYNE2 PNPLA3	2.07e-03	264	146	6	EFO_0008317, EFO_0020944
Disease	cholesterol to total lipids in small VLDL percentage	BANF2 GCKR JMJD1C	2.08e-03	51	146	3	EFO_0022242
Disease	dystonia (is_implicated_in)	VPS16 NUP54	2.13e-03	14	146	2	DOID:543 (is_implicated_in)
Disease	nephroblastoma (is_implicated_in)	IGF2R TIMP4	2.13e-03	14	146	2	DOID:2154 (is_implicated_in)
Disease	triacylglycerol 46:2 measurement	GCKR CSMD1	2.13e-03	14	146	2	EFO_0010402
Disease	triacylglycerol 52:1 measurement	GCKR CSMD1	2.13e-03	14	146	2	EFO_0010413
Disease	triglyceride measurement, intermediate density lipoprotein measurement	GCKR IGF2R SYNE2 PNPLA3	2.29e-03	111	146	4	EFO_0004530, EFO_0008595
Disease	triglycerides to total lipids in very large VLDL percentage	BANF2 GCKR JMJD1C	2.32e-03	53	146	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	BANF2 GCKR JMJD1C	2.32e-03	53	146	3	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	BANF2 GCKR JMJD1C	2.45e-03	54	146	3	EFO_0022244
Disease	liver volume	GCKR JMJD1C	2.45e-03	15	146	2	EFO_0600048
Disease	triglycerides in LDL measurement	GCKR IGF2R SYNE2	2.72e-03	56	146	3	EFO_0022320
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	DIP2B GCKR PKD1L3	2.72e-03	56	146	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	liver fat measurement, liver disease biomarker	GCKR PNPLA3	2.79e-03	16	146	2	EFO_0006845, EFO_0010821
Disease	Psoriasis	IL23A GJB2 CSMD1	2.86e-03	57	146	3	C0033860
Disease	free cholesterol to total lipids in medium VLDL percentage	BANF2 GCKR JMJD1C	2.86e-03	57	146	3	EFO_0022284
Disease	Pustulosis of Palms and Soles	IL23A GJB2 CSMD1	2.86e-03	57	146	3	C0030246
Disease	glycoprotein measurement	GCKR PKD1L3 PRAG1 PNPLA3	2.94e-03	119	146	4	EFO_0004555
Disease	triglycerides to total lipids in small VLDL percentage	BANF2 GCKR JMJD1C	3.00e-03	58	146	3	EFO_0022338
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	GCKR JMJD1C SYNE2 PNPLA3	3.12e-03	121	146	4	EFO_0008595, EFO_0020943
Disease	fasting blood glucose measurement	DSCAM GCKR JMJD1C SLC24A4 CSMD1 MAP4K2	3.13e-03	287	146	6	EFO_0004465
Disease	triacylglycerol 48:1 measurement	GCKR CSMD1	3.15e-03	17	146	2	EFO_0010404
Disease	free cholesterol to total lipids in very large VLDL percentage	BANF2 GCKR JMJD1C	3.15e-03	59	146	3	EFO_0022289
Disease	total lipids in VLDL measurement	GCKR JMJD1C IGF2R	3.30e-03	60	146	3	EFO_0022314
Disease	cholesterol to total lipids in IDL percentage	GCKR JMJD1C PNPLA3	3.30e-03	60	146	3	EFO_0022233
Disease	acne	FCHO2 PRAG1 EDAR PNPLA3	3.51e-03	125	146	4	EFO_0003894
Disease	puberty onset measurement	GCKR JMJD1C KCNA7 HERC2	3.51e-03	125	146	4	EFO_0005677
Disease	cutaneous melanoma, hair color	SLC24A4 SYNE2 HERC2	3.63e-03	62	146	3	EFO_0000389, EFO_0003924
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	ACACB GCKR IGF2R SYNE2 MAP4K2	3.68e-03	206	146	5	EFO_0004612, EFO_0020947
Disease	triglycerides to total lipids in medium VLDL percentage	BANF2 GCKR JMJD1C	3.79e-03	63	146	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	BANF2 GCKR JMJD1C	3.79e-03	63	146	3	EFO_0022239
Disease	fish consumption measurement	ADGRB3 NAA25 ATXN1	3.97e-03	64	146	3	EFO_0010139
Disease	cholesteryl esters to total lipids in medium VLDL percentage	BANF2 GCKR JMJD1C	3.97e-03	64	146	3	EFO_0022253
Disease	cystatin C measurement	INTU GCKR CEMIP NAA25 RPAP1 EDAR PKHD1	3.98e-03	402	146	7	EFO_0004617
Disease	white matter hyperintensity measurement	ACOX1 FCHO2 PRAG1 GFM2 KCNA5 SHOC1	4.01e-03	302	146	6	EFO_0005665
Disease	cholesterol in large VLDL measurement	GCKR JMJD1C IGF2R	4.14e-03	65	146	3	EFO_0021902
Disease	triacylglycerol 46:1 measurement	GCKR CSMD1	4.36e-03	20	146	2	EFO_0010401
Disease	common carotid intimal medial thickness	PRAG1 RYR3 CD180	4.51e-03	67	146	3	EFO_0004860
Disease	alkaline phosphatase measurement	TRIM2 ACACB BANF2 GCKR FCHO2 PKD1L3 PRAG1 JMJD1C NOP58 EIF2B2 MIEF1 MAP4K2	4.69e-03	1015	146	12	EFO_0004533
Disease	fatty acid measurement, linoleic acid measurement	GCKR NAA25 PNPLA3	4.70e-03	68	146	3	EFO_0005110, EFO_0006807
Disease	synophrys measurement	SLC24A4 EDAR HERC2	4.70e-03	68	146	3	EFO_0007906
Disease	saturated fatty acids to total fatty acids percentage	GCKR PNPLA3	4.80e-03	21	146	2	EFO_0022305
Disease	prothrombin time measurement	GCKR JMJD1C	4.80e-03	21	146	2	EFO_0008390
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	GCKR PNPLA3	4.80e-03	21	146	2	EFO_0022277
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	BANF2 GCKR JMJD1C IGF2R	4.86e-03	137	146	4	EFO_0004611, EFO_0008591
Disease	susceptibility to mononucleosis measurement	CUL1 RYR2 MDN1	4.90e-03	69	146	3	EFO_0008403
Disease	breast size	GCKR LMOD1 CDON	4.90e-03	69	146	3	EFO_0004884

Protein segments in the cluster

Peptide	Gene	Start	Entry
KLGTLAEGSLQLHLQ	CEP295NL	476	Q96MC4
LLQGTLAQSIKGNHL	CD3G	16	P09693
HSQLVNKLLVAGATV	ANKRD23	156	Q86SG2
SHKNSVLSQGGVALV	CSMD1	331	Q96PZ7
VLLQSTESKLHLQGL	BRINP1	216	O60477
FLGSVLTLLQKQHAL	BPIFB4	426	P59827
ILILVGQTQTHNKSI	ADGRB3	926	O60242
LGHSGAGKTTLLNIL	ABCA9	516	Q8IUA7
AAQQGHTDIVTLLLK	ANK1	741	P16157
IIGSLSNAIKEIHLQ	FCHO2	216	Q0JRZ9
TLAAHQAIGLKGIIL	ACAD9	141	Q9H845
SKNITSGLHFGLVNI	AGTR2	11	P50052
TLGILKNGTSALHAA	ANKRD29	236	Q8N6D5
ITVLLGHNGAGKTTT	ABCA3	561	Q99758
QLVTQVHVLGAAGLK	CAPN5	516	O15484
SNLLLSHAGILKVGD	CDK11B	566	P21127
LQTILGGVNKHSTSI	GJB2	6	P29033
GHLETVNLLLNKGAS	ANKRD52	151	Q8NB46
LQQGIGLHKALSTGL	ATXN1	71	P54253
SLKHLFLIQTGISNL	CD180	126	Q99467
VHIGQGKTLLLTSSA	CEMIP	56	Q8WUJ3
LGRVNLVSGHVKTQL	DCAF7	156	P61962
SLLVTGKIVDHVNGT	NXPH4	121	O95158
LGSVALTVLGIHLNK	SLC24A4	566	Q8NFF2
THAKVQGAGQLRLSI	RGS3	131	P49796
GLGKTVQSIALLAHL	INO80	546	Q9ULG1
HGILLITKVFLGQSV	LRRC9	546	Q6ZRR7
VNNVLLSLSGKSTHI	MAP4K2	536	Q12851
HIILTGASALNKVLG	ACACB	1956	O00763
LNLAKHAASTVQILG	NOP58	306	Q9Y2X3
NHLISKGLGETATVL	DCAF1	856	Q9Y4B6
KSGLGLVHQEGSQLT	FAM171A1	256	Q5VUB5
GKTSLVQLLAHLTGH	MDN1	2071	Q9NU22
LKVLLHSLGLVGNSV	MDN1	2326	Q9NU22
VTLKQTHLNSGVILS	NELL2	91	Q99435
NSIGKSNLVISLHVQ	LRIT2	331	A6NDA9
GVQLLAVSHVGIKLL	MYO15A	2786	Q9UKN7
ISLIGQGKTSDHLIF	GPR158	556	Q5T848
GLGSILLNSLKQTVV	HERC2	856	O95714
KITHLSTLQVGSLNV	HAGH	136	Q16775
TLIHLVQGLGADSKN	IPO11	626	Q9UI26
LGNVILALVNGSKHI	KIF26B	736	Q2KJY2
VVHSLLKGENIGITS	JMJD1C	246	Q15652
KELSGQGHLATALII	EDAR	176	Q9UNE0
TLRKELILSSNIGQH	MTIF3	156	Q9H2K0
SLNLDSNHITGKGIL	LMOD1	391	P29536
VHQLISGKIGISLTR	PNPLA3	106	Q9NST1
LLASVIQTGHLAKLQ	LRRC31	441	Q6UY01
GIHISQTKQLFLEGS	DIP2B	911	Q9P265
GNLHLIHVTSKQTLL	KNTC1	106	P50748
HLSLANNKITTINGL	LRGUK	241	Q96M69
IAVQTTAGKQLSLTH	HEG1	871	Q9ULI3
ALGHLTASQLTNVIL	MIEF1	376	Q9NQG6
SQLVLQAISTHKGLT	H1-7	61	Q75WM6
GSQLGLSVLSKLSQL	HUWE1	926	Q7Z6Z7
TSSALKGAIQLGITH	PIP5K1A	81	Q99755
KGAIQLGITHTVGSL	PIP5K1A	86	Q99755
HGLLSKSVQLNGLTL	HPSE	486	Q9Y251
LLLGIGLQHKSVDQL	NAT10	866	Q9H0A0
ALKGAIQLGITHTVG	PIPSL	31	A2A3N6
IQLGITHTVGSLSTK	PIPSL	36	A2A3N6
LLTQNNSKFHLGSII	GRIN3A	281	Q8TCU5
LLGGVAHTLQKTLQT	PLIN1	331	O60240
LNTVSTGAHVLLGKI	GCKR	486	Q14397
QVTSSSLLLNGKQIH	INTU	361	Q9ULD6
ESLHKVLGGNQTLTV	NUP54	211	Q7Z3B4
LITQGLISKGILSSH	OCIAD1	56	Q9NX40
QKLGKSGHLQVNTTL	RGR	201	P47804
GKTSNHAIVLAQLIT	ACOX1	181	Q15067
IGSGQHLKTSVSILL	HEATR5B	926	Q9P2D3
HSKGLQILGKTLQAS	KCNA5	416	P22460
LSRHSKGLQILGQTL	KCNA7	291	Q96RP8
VGIKALTNHGTANIS	BPIFC	101	Q8NFQ6
GISHELAINLVTKGI	BANF2	26	Q9H503
KISDLTLGHVNGLQL	CRHBP	216	P24387
KHQQLLGEVLTQLSS	CUL1	726	Q13616
GISHVINTKTNLVAL	FRMPD4	446	Q14CM0
KIHQGTLTILSLNSS	CDON	76	Q4KMG0
KGLQDQIVSLGATVH	CDON	316	Q4KMG0
NTLIGTLNVHTVFLK	COBL	121	O75128
VGQLHASLLGLSQLL	IL23A	121	Q9NPF7
LSNSHLVLIGIANTL	CDC6	306	Q99741
NKVTHGLVTVEGQLT	CCP110	471	O43303
SLGKLELQHISSINV	LYST	1061	Q99698
IHQLLTNGGLAKLAS	KANSL3	826	Q9P2N6
QESLHKLLTSGGLNE	EIF2B2	106	P49770
QGLQGLKLFIRSSVH	CENPI	726	Q92674
ILSSVTHNGKQLVLT	RYR2	4756	Q92736
THNGKQLVLTVGLLA	RYR2	4761	Q92736
KSTTTIGLVQALGAH	MTHFD1	386	P11586
NLTGKGITQILGKSH	C18orf63	571	Q68DL7
FHLLKGTSLNVVVLN	FPGT	351	O14772
LVIHNDGTKLLVLNS	LRRC8D	616	Q7L1W4
KEVGLANLTQLTTLH	LRRN1	111	Q6UXK5
HLVKLVLGNLSGTDQ	PTPN13	171	Q12923
LQKLEQHGGSGSLSI	PACRGL	221	Q8N7B6
LSGHVSTVKLLLENN	INVS	366	Q9Y283
LTGLTTIAAHLVKQA	EEF1E1	41	O43324
GRIQVLSNGSLLIKH	DSCAM	741	O60469
TGDVQVLGLVHTQKL	IGF2R	2051	P11717
RHTGQIGGLKLLSNS	TARS2	246	Q9BW92
LHLGSNQITVIKGDV	SLITRK4	406	Q8IW52
GILNSLEIVLKNISH	UTP20	1096	O75691
IAHGVFSGSLNILLK	SLC35D3	16	Q5M8T2
SLTAGNIALTVGLKH	GFM2	426	Q969S9
VLGTLISILKNQLGH	SLC47A2	381	Q86VL8
LNKTETGALVLHNIG	SYNE2	2481	Q8WXH0
TAVISIGNQLLHLKE	SYNE2	5006	Q8WXH0
GSAGLLQQILSLKVV	TMEM170A	11	Q8WVE7
SVLIVGQHILKNGLS	YARS2	446	Q9Y2Z4
ALGLHLQAALTASKV	PTCH2	131	Q9Y6C5
LGIISNKQTHTSAIV	SMG7	126	Q92540
QRLKSHLGTLGLTQG	PKD1L3	1081	Q7Z443
HLASANGNSGVVKLL	POTEJ	141	P0CG39
LNKIEGLTLTVLHSN	SHOC1	761	Q5VXU9
KALTSGAALHVLLSQ	SLC26A10	151	Q8NG04
LDTNTSILNLLHIKG	PKHD1	1956	P08F94
LTVGAQGHVLLLRSQ	ITGAM	601	P11215
GLGKTIQTISLLAHL	SRCAP	646	Q6ZRS2
GHQGVIKLLVQRLAS	SOWAHB	681	A6NEL2
QTLIHLLKCNIGTGL	SLC36A3	46	Q495N2
AHSVTKTQILQGLGF	SERPINA9	86	Q86WD7
KTQILQGLGFNLTHT	SERPINA9	91	Q86WD7
SSLNLKGVQIHTSVV	ERVK-9	706	P63128
AKIQLQLVLHAGDTT	GTF2H1	61	P32780
GKGCITLSQLTLHQR	ZNF624	786	Q9P2J8
GATVGVLLDLNKHTL	TRIM67	716	Q6ZTA4
QLFVGLKVHLSTGEL	EEFSEC	501	P57772
GTLDLSLTVQGKQHV	THBS1	126	P07996
AVTITLNSKLLGGNI	YIPF6	131	Q96EC8
QTLIHLLKGNIGTGL	SLC36A1	51	Q7Z2H8
GQAVRLTHVLTGKNL	SDF2L1	101	Q9HCN8
IVALTAGTKTLQHNL	SLC35A5	161	Q9BS91
GTLSVLKVLVLNQTG	TBCE	201	Q15813
HGIKTVSQIISLQTL	RSL1D1	121	O76021
LRTILSSVTHNGKQL	RYR3	4656	Q15413
SSVTHNGKQLVLTVG	RYR3	4661	Q15413
LHDTVTTLILGGHNK	VPS16	696	Q9H269
TTLILGGHNKRAEQL	VPS16	701	Q9H269
TKGLSILTHDVQSQL	TLNRD1	86	Q9H1K6
LTGQVLSDGKVFIHL	TIMP4	116	Q99727
TIELKNGTQVHGTIT	SNRPD1	16	P62314
ALLSLLNTLAQIHKG	RPAP1	896	Q9BWH6
HSILGEQTKALVTQL	THBS3	221	P49746
LQLHGLLSNISSKEG	PRAG1	936	Q86YV5
TLTITAGNVKHILNA	ZBTB7C	96	A1YPR0
QLKHTNIFTLLVLVG	ZZEF1	2236	O43149
TLNTLIKIIGNSVGA	SCN11A	686	Q9UI33
LLNVSGHVKESGQVL	TGM1	666	P22735
LGLLVTGTIVVSQHA	TBXA2R	76	P21731
LAVVQKSTHLIGSGS	ZSWIM1	346	Q9BR11
EGLKKSIHNLGTILT	TRIM2	306	Q9C040
IQSSKLLLHQIIHTG	ZNF623	441	O75123
AKDLGTLVAGHTLQI	TGM7	656	Q96PF1
TLNQHGIKDGLTVHL	UBQLN4	66	Q9NRR5
IGIHSRTSLLQLTQK	WDR87	981	Q6ZQQ6
GKIFNSSINIVHVGL	ZNF605	76	Q86T29
TSKGLHFNNLIVGLV	USP32	71	Q8NFA0
NALGKAVATSVLHLL	ADAMTSL3	1371	P82987
KLVLLQSSAVLLHSG	MXRA8	11	Q9BRK3
GLQTLISNVVDHIKG	NAA25	896	Q14CX7